Total Payments
$10,141
2024 Payments
$1,756
Companies
38
Transactions
657
Medicare Patients
2,835
Medicare Billing
$720,712
Payment Breakdown by Category
Food & Beverage$10,141 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,141 | 657 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,525 | 203 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $837.61 | 75 | $0 (2024) |
| Janssen Biotech, Inc. | $658.33 | 36 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $612.32 | 29 | $0 (2024) |
| QOL Medical, LLC | $567.10 | 31 | $0 (2024) |
| Daiichi Sankyo Inc. | $525.95 | 26 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $514.42 | 33 | $0 (2024) |
| Celgene Corporation | $479.05 | 47 | $0 (2024) |
| Allergan Inc. | $351.35 | 17 | $0 (2018) |
| Merck Sharp & Dohme LLC | $341.89 | 19 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,756 | 102 | ABBVIE INC. ($430.26) |
| 2023 | $1,784 | 117 | ABBVIE INC. ($403.98) |
| 2022 | $1,935 | 137 | ABBVIE INC. ($564.97) |
| 2021 | $1,418 | 100 | AbbVie Inc. ($286.38) |
| 2020 | $409.32 | 26 | AbbVie Inc. ($157.93) |
| 2019 | $1,442 | 98 | AbbVie, Inc. ($337.36) |
| 2018 | $1,078 | 65 | AbbVie, Inc. ($264.98) |
| 2017 | $317.81 | 12 | Allergan Inc. ($166.41) |
All Payment Transactions
657 individual payment records from CMS Open Payments — Page 25 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/21/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Immunology | ||||||
| 09/13/2018 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $17.57 | General |
| Category: Allergy/Immunology | ||||||
| 09/10/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Immunology | ||||||
| 09/06/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Gastroenterology | ||||||
| 09/05/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $12.80 | General |
| 08/29/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Lower GI | ||||||
| 08/24/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Immunology | ||||||
| 08/23/2018 | Echosens North America, Inc. | Fibroscan (Device) | Food and Beverage | Cash or cash equivalent | $16.17 | General |
| Category: Elastography | ||||||
| 08/17/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/15/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Anemia | ||||||
| 08/14/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Immunology | ||||||
| 08/09/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Gastroenterology | ||||||
| 08/06/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Endocrinology | ||||||
| 07/27/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Immunology | ||||||
| 07/25/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/19/2018 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $85.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/19/2018 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $54.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/13/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Lower GI | ||||||
| 07/10/2018 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/10/2018 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $0.74 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 06/27/2018 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Immunology | ||||||
| 06/27/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/15/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/15/2018 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $0.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/12/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Lower GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 677 | 716 | $744,089 | $215,676 |
| 2022 | 13 | 717 | 760 | $617,638 | $180,492 |
| 2021 | 13 | 736 | 791 | $553,346 | $169,801 |
| 2020 | 16 | 705 | 758 | $552,132 | $154,744 |
Total Patients
2,835
Total Services
3,025
Medicare Billing
$720,712
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 63 | 63 | $32,286 | $4,372 | 13.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $9,916 | $3,808 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 45 | $5,400 | $2,812 | 52.1% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2022 | 16 | 28 | $4,900 | $1,964 | 40.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 16 | 17 | $7,531 | $1,653 | 21.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $3,960 | $1,574 | 39.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $7,080 | $601.18 | 8.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Office | 2021 | 120 | 120 | $150,000 | $45,759 | 30.5% |
| 43249 | Balloon dilation of esophagus, stomach and upper small bowel using a flexible endoscope | Office | 2021 | 26 | 27 | $62,100 | $26,165 | 42.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 73 | 75 | $82,500 | $18,099 | 21.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2021 | 32 | 32 | $36,800 | $11,490 | 31.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 84 | 99 | $17,325 | $9,378 | 54.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 43 | 44 | $21,296 | $8,666 | 40.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 34 | 34 | $39,100 | $8,368 | 21.4% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2021 | 15 | 32 | $20,000 | $7,166 | 35.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2021 | 16 | 16 | $18,400 | $5,750 | 31.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 65 | $7,800 | $4,235 | 54.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 56 | 56 | $10,080 | $4,198 | 41.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 60 | 61 | $30,683 | $4,124 | 13.4% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Office | 2021 | 14 | 14 | $16,100 | $3,674 | 22.8% |
| 91065 | Measurement of hydrogen in breath to test for gi symptoms | Office | 2021 | 22 | 36 | $6,300 | $2,617 | 41.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $5,092 | $2,462 | 48.4% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 16 | 16 | $6,064 | $2,287 | 37.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 11 | 11 | $6,292 | $2,080 | 33.1% |
| 43249 | Balloon dilation of esophagus, stomach and upper small bowel using a flexible endoscope | Facility | 2021 | 18 | 18 | $7,974 | $1,868 | 23.4% |
About Dr. Patrick Kenny, DO
Dr. Patrick Kenny, DO is a Internal Medicine healthcare provider based in Lynchburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1174509491.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Kenny, DO has received a total of $10,141 in payments from pharmaceutical and medical device companies, with $1,756 received in 2024. These payments were reported across 657 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($10,141).
As a Medicare-enrolled provider, Kenny has provided services to 2,835 Medicare beneficiaries, totaling 3,025 services with total Medicare billing of $720,712. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Lynchburg, VA
- Active Since 12/19/2005
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174509491
Products in Payments
- ZEPOSIA (Drug) $664.03
- Linzess (Drug) $612.32
- RINVOQ (Biological) $553.58
- INJECTAFER (Drug) $525.95
- XIFAXAN (Drug) $469.99
- ENTYVIO (Biological) $442.50
- VIBERZI (Drug) $427.34
- SUCRAID (Drug) $390.51
- HUMIRA (Biological) $389.12
- Humira (Biological) $386.16
- DIFICID (Drug) $314.37
- DUPIXENT (Biological) $299.73
- CREON (Drug) $292.53
- LINZESS (Drug) $276.16
- XELJANZ (Drug) $256.41
- STELARA (Biological) $248.11
- SKYRIZI (Biological) $246.79
- TREMFYA (Drug) $240.79
- Cimzia (Drug) $238.01
- ZENPEP (Drug) $214.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lynchburg
Dr. Julia Mchugh, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $31,277
Internal Medicine $31,277
Juan Aponte, Md, MD
Internal Medicine — Payments: $9,659
Internal Medicine $9,659
Richard Miller, Md, MD
Internal Medicine — Payments: $8,691
Internal Medicine $8,691
Dr. Kenneth Musana, Md, MD
Internal Medicine — Payments: $8,380
Internal Medicine $8,380
Dr. Evan Ownby, Md, MD
Internal Medicine — Payments: $3,602
Internal Medicine $3,602
Dr. Michael Cook, Md, MD
Internal Medicine — Payments: $3,493
Internal Medicine $3,493